Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
NCT06051604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172
Last updated 2024-09-26
Summary
This is a prospective, double-blind, sham-controlled, randomized clinical trial . This study aims to assess the efficacy, safety, tolerability, and the optimal dose of the Mi-Helper transnasal cooling device for acute treatment of migraine in an at home setting.
Adults aged 18 years to 65 years old with a diagnosis of episodic migraine (with or without aura) for at least one year (self-reported) will be recruited for this study.
Conditions
- Episodic Migraine
- Migraine With Aura
- Migraine Without Aura
- Migraine
Interventions
- DEVICE
-
Mi-Helper
The Mi-Helper device is a non-invasive, drug-free, novel therapy that uses a patented process of dry air flow across the nasal turbinates to induce a phase change (evaporation) that extracts energy (thermodynamics) causing local cooling which modulates nerves associated with pain and other symptoms of migraine. The device delivers a controlled pressure and flow of dry room temperature air along with a nebulized saline mist for added comfort and evaporative efficiency.
Sponsors & Collaborators
-
ObvioHealth
collaborator INDUSTRY -
CoolTech LLC
lead INDUSTRY
Principal Investigators
-
Parth Shah, MD · ObvioHealth
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-15
- Primary Completion
- 2024-06-18
- Completion
- 2024-09-24
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine
NCT06554886 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
NCT02638103 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Cooling for Symptomatic Relief of Migraine
NCT02375789 ·Status: TERMINATED ·Phase: NA
-
Intranasal Cooling for Cluster Headache and Migraine
NCT01898455 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of MigraineBoxTM Head and Neck Cooling Bath for Treatment of Primary Headache in the Emergency Department
NCT01977001 ·Status: COMPLETED
-
A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
NCT00510419 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief
NCT03263897 ·Status: TERMINATED ·Phase: NA
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692 ·Status: WITHDRAWN
-
A Study of Wearable Devices to Predict Migraines
NCT05755945 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
PArtial REbreathing for Migraine With Aura 1
NCT05546385 ·Status: TERMINATED ·Phase: NA
-
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
NCT06602479 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults
NCT06728553 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a New Treatment for Migraine Attacks
NCT01880671 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
NCT06103734 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack
NCT00530517 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
NCT02621931 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine
NCT00567086 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence
NCT05769322 ·Status: COMPLETED
-
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
NCT03308968 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Novel Device for Treatment of Migraine Headache
NCT03361423 ·Status: COMPLETED ·Phase: NA
-
An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute Migraine
NCT02764996 ·Status: COMPLETED ·Phase: NA
-
The Utility of Telemedicine in the Management of Migraine
NCT01706003 ·Status: COMPLETED